Ovid Therapeutics (OVID) IPO Opens 7% Lower

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. AAPL
10. SPY

Go back to Ovid Therapeutics (OVID) IPO Opens 7% Lower

Ovid Therapeutics Announces Pricing of Initial Public Offering

May 4, 2017 6:20 PM EDT

NEW YORK, May 04, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc., a biopharmaceutical company, announced today that it has priced its initial public offering of 5,000,000 shares of its common stock at a public offering price of $15.00 per share, for an aggregate offering of $75 million, before underwriting discounts, commissions and expenses. In addition, Ovid Therapeutics has granted the underwriters a 30-day option to purchase up to 750,000 additional shares of common stock at the initial offering price to cover over-allotments, if any. All of the common stock is being offered by Ovid Therapeutics.

The common stock will... More